Economic sentiment for Europe rises, while that of Germany deteriorates
Source link
Lilly weight-loss pill orforglipron could get FDA approval by 2026, CEO Dave Ricks says
Eli Lilly & Co., the Fortune 500 pharma firm that makes weight-loss injection Zepbound (tirzepatide), has a comparable oral drug in the works that could be approved by the FDA…